United States Nuclear Regulatory Commission - Protecting People and the Environment

W18  Progress Toward a Reliable Domestic Supply of Molybdenum-99

The NRC has issued construction permits for new facilities designed for the domestic production of molybdenum-99, a precursor to the principal isotope in nuclear medicine for diagnostic imaging—technetium-99m. In preparation for anticipated construction activities and submissions of operating license applications, the NRC staff is updating its construction inspection procedures, developing operation inspection procedures, finalizing guidance, and considering the impact of proposed rulemakings on potential medical isotope facilities. This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensees, and other stakeholders.

SESSION CHAIR(S):
 

SPEAKER(S):
 

SESSION COORDINATOR(S):
 
  • Cindy Montgomery, Project Manager, Division of Licensing Projects, NRR/NRC tel: 301-415-3398, e-mail: Cindy.Montgomery@nrc.go
Page Last Reviewed/Updated Monday, June 04, 2018